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Background: The aim of this study was to compare the risk for mental health disorders between smokers and
non-smokers and to assess the risk for depression and anxiety according to addiction severity.
Methods: This cross-sectional study assesses the mental health status and relationship with the severity of nicotine
addiction in a sample of smokers admitted to Pamukkale University Hospital Smoking Cessation Clinic (n = 101) from 1
June 2012 to 31 August 2012 compared to a group of non-smokers from the general population (n = 101). We
conducted semi-structured face-to-face interviews to collect sociodemographic data; we assessed the participants’
mental health status with the General Health Questionnaire-12 (GHQ-12) and the Hospital Anxiety and Depression Scale
(HADS), and we measured nicotine addiction severity with the Fagerström Test.
Results: The risk for mental illness reported by smokers based on the GHQ-12 was significantly higher than that for
non-smokers (p = 0.001). The anxiety and depression scores according to HADS were higher among smokers (16.8%
and 22.8%, respectively) than non-smokers (4.0% and 5.0%, respectively) (p = 0.006 and p = 0.001, respectively). The
nicotine addiction severity was higher in smokers with higher anxiety and depression scores (p = 0.008).
Conclusions: We found high scores for mental illness in treatment-seeking smokers compared with non-smokers. The
risk for anxiety and depression was higher among smokers. Increased nicotine addiction severity was associated with
increased risk for mental illness and increased scores of anxiety and depression.
Keywords: Smoking cessation, Nicotine addiction, Mental health, Anxiety, DepressionBackground
Tobacco is the single most preventable cause of death in
the world today, and it is the leading cause of disease, dis-
ability, and death in both developed and developing coun-
tries. According to The World Health Organization’s
Global Status Report on Noncommunicable Diseases 2010,
tobacco kills nearly 6 million people per year. As the lead-
ing behavioural risk factor for noncommunicable diseases,
smoking is estimated to be responsible for approximately
71% of all lung cancer deaths, 42% of chronic respiratory
disease cases and nearly 10% of cardiovascular disease
cases [1-3].* Correspondence: ktopal9@yahoo.com
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unless otherwise stated.The best method for reducing tobacco-related morbidity
and mortality is to quit smoking. Professional help and
medical treatment significantly increase the cessation rates.
Smoking cessation clinics are effective for smoking cessa-
tion [4-8]. In Turkey, there are more than 300 smoking
cessation clinics, and in general, pulmonologists work at
these clinics. Assessing the physiological, psychological,
and social factors is important for success, so the health
professionals who work in smoking cessation clinics should
be well-trained. Additionally, it is important for the health
professionals working in smoking cessation clinics to have
a multidisciplinary perspective.
Smokers have a higher mental illness risk than non-
smokers; therefore, it is important to screen smokers for
mental illness. Breslau et al. [4] demonstrated that major
depression and anxiety disorder rates are higher in people
with nicotine addiction, and the rates increased with thetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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relationship may be causal in either direction; that is, nico-
tine addiction may lead to major depression, and major
depression can affect nicotine use [9,10]. Black et al. [11]
examined the prevalence of lifetime psychiatric disorders
in cigarette smokers and non-smokers in the general
population and found that smokers more often had a his-
tory of major depression, alcohol and substance addiction,
agoraphobia and other personality disorders. Nicotine ad-
diction was 4 to 6 times more frequent in people with de-
pression. Lifetime tobacco product use was higher in
people with depression than in those without. Also, there
is a reported correlation between higher depression scores
and increased smoking rates [11].
The aim of this study was to assess the psychological
health, anxiety and depression risk in smokers who de-
sired to quit compared to non-smokers and to look for a




This cross-sectional study included 101 smokers who were
admitted to the Pamukkale University Hospital Smoking
Cessation Clinic from 1 June 2012 to 31 August 2012 and
101 age- and gender-matched non-smokers from the general
population. Participants were 18 to 65 years of age. Patients
with a previous diagnosis of any mental illness were excluded
from the study. The researchers prepared a questionnaire to
collect sociodemographic data, including income level, edu-
cational status, smoking habits, alcohol consumption, and
spouse’s and children’s smoking habits. The questionnaires
were completed during face-to-face interviews.
All of the participants gave written informed consent.
The study was conducted according to the Declaration of
Helsinki Principles and was approved by the Pamukkale
University Faculty of Medicine Ethics Committee.
Scales
The Fagerström Test for Nicotine Dependence (FTND)
was used to measure the degree of nicotine dependence.
Fagerström and Schneider developed this scale in 1989
to determine the degree of nicotine addiction, and this
scale is often used to measure physical dependence on
nicotine. The FTND is a well-validated psychometric
assessment tool that consists of six questions. The total
possible score ranges from 0 (no dependence) to 10
(very high dependence) and can be categorised as ‘low
dependence’ (score 0–3), ‘medium dependence’ (score
4–6), or ‘high dependence’ (score 7–10) [12,13].
The General Health Questionnaire-12 (GHQ-12) was
used to assess mental health in both groups. The GHQ-12
was developed to determine the mental condition in the
community and primary health care facilities. It is one ofthe most commonly used scales and consists of 12 items,
each assessing the severity of a mental problem over the
past few weeks using a 4-point Likert-type scale. Higher
scores indicate worse health. Participants with an average
total GHQ 12 score above the cut-off threshold (11/12)
were considered potential cases of psychological disorders
[14,15]. Validity and reliability studies of the GHQ-12 in
Turkey have been conducted by Kilic et al. [16,17].
The Hospital Anxiety and Depression Scale (HADS)
was administered to participants who were considered
to be at risk for mental problems based on the GHQ-12,
and it was used to assess the risk for anxiety and depres-
sion. Responses are based on the relative frequency of
symptoms over the past week according to a four-point
Likert scale, ranging from 0 (not at all) to 3 (very often
indeed), and they are summed to provide separate scores
for anxiety and depression symptomology; each anxiety
or depression scale has a score ranging from 0–21.
Higher scores indicate a greater likelihood of depression
or anxiety, wherein a cut-off point of (10/11) is consid-
ered for Anxiety and (7/8) for the Depression subscale
[18,19]. All scales were self-administered. The flow chart
of the study activities is provided in Figure 1.
Statistical analysis
We used two independent sample t-tests for qualitative
variables and Chi-Square tests or the Fisher’s exact test
for categorical variables. We compared the two groups’
sociodemographic variables, including age, gender, marital
status, mean income, educational status, spouse’s smoking
behaviour, children’s smoking behaviour, alcohol con-
sumption and the risk for mental health disorders based
on GHQ-12 and the risk for anxiety and depression based
on HADS. We analysed the relationship between gender
and the level of nicotine dependency (FTND score) as well
as the relationship between the risk for mental health dis-
orders based on GHQ-12 and risk for anxiety and depres-
sion based on HADS. Logistic regression analysis (LRA)
was used to estimate the simultaneous effects of age, gen-
der, marital status, mean income, educational status, al-
cohol consumption and positive risk for anxiety and
depression based on HADS. A two-tailed p value less
than 0.05 was considered significant.
Results
The sociodemographic characteristics of the partici-
pants are presented in Table 1. The mean age was
39.4 ± 12.7 years (range = 18-65 years), and 132 partici-
pants were male (65.3%). There were no significant differ-
ences between the smoker and comparison groups in
terms of male gender (68.3% of smokers and 62.4% of
the comparison group, p = 0.375) and mean age (38.9 ±
12.0 years in the smoker group and 39.9 ± 13.3 years in
the comparison group, p = 0.539). There was a significant
Figure 1 Research flow chart.
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smokers were married compared with 80.1% in the com-
parison group (p = 0.002). The percentage of smokers at
the mean income level (31.9%) was significantly lower
than that in the comparison group (49.5%) (p = 0.04).Table 1 Sociodemographic characteristics and the risk for me
Smo
Age (Year) (mean ± SD) 38.9
Gender (Male) 69 (6
Marital status (Married) 63 (6
Mean income Base wage rate or lower 46 (5
Two or three times the base wage rate 29 (3
Higher than three times the base wage rate 16 (1
Educational status Primary school and under 49 (4
High school 49 (4
University or higher 3 (3.0
Spouse’s smoking 21 (3
Children smoking 13 (2
Alcohol consumption 36 (3
The risk for mental illness based on GHQ-12 38 (3
The risk for anxiety based on HADS 17 (1
The risk for depression based on HADS 23 (2
The risk for anxiety and depression based on HADS 12 (1
†p < 0.05, ††p < 0.01, *t-test for equality of means used for only this line, a likelihood
Questionnaire, HADS: Hospital Anxiety and Depression Scale).There was no significant difference between the two
groups in terms of educational status (p = 0.797) (Table 1).
The smoking status of the participants’ spouses and
children was also investigated. The smoking rates were
higher for the spouses and children of smokers (33.3%ntal illness based on GHQ-12 and HADS
ker group(n = 101) Comparison group(n = 101) X2 p
± 12.0 39.9 ± 13.3 0.6* 0.539
8.3%) 63 (62.4%) 0.8 0.375
2.4%) 81 (80.1%) 14.3 0.002†
0.5%) 37 (40.7%) 6.5 0.040†
1.9%) 45 (49.5%)
7.6%) 9 (9.9%)
8.5%) 46 (45.5%) 0.5 0.797
8.5%) 53 (52.5%)
%) 2 (2.0%)
3.3%) 12 (14.8%) 6.9 0.009††
1.3%) 6 (7.9%) 3.8 0.052
5.6%) 6 (5.9%) 25.3 0.001††
7.6%) 8 (7.9%) 23.7 0.001††
6.8%) 4 (4.0%) 7.7 0.006†
2.8%) 5 (5.0%) 12.0 0.001††
1.9%) 3 (3.0%) 4.6 0.032†
ratio chi-square test was used for the following lines. (GHQ: General Health
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dren of the comparison group (14.8% and 7.9%, respect-
ively). The spouses’ smoking behaviour was significantly
higher in smokers compared to the comparison group
(p = 0.009), whereas children’s smoking behaviour was not
significantly different between the groups (p = 0.052).
There was a significant relationship between smoking
and alcohol use. The smokers’ alcohol consumption was
six times greater than that of non-smokers (p = 0.001).
The GHQ-12 scale results were significantly related to
smoking behaviour.
Smokers reported a high score, above the threshold
for mental illness, 4.5 times more frequently than non-
smokers; 38 (37.6%) smokers reported a high score that
was above the threshold for mental illness compared
with only eight people (7.9%) in the comparison group
(p = 0.001). Participants who reported a high score above
threshold for mental illness according to the GHQ-12
completed HADS. The risk for anxiety in smoker group
(n = 17, 16.8%) was higher than that of the comparison
group (n = 4, 4.0%), (p = 0.006). In the smoker group, 23
people (22.8%) were at risk for depression, whereas five
people (5.0%) in the comparison group were at risk for
depression (p = 0.001). The risk for depression and anx-
iety was 3% in the comparison group and 11.9% in the
smoker group (p = 0.032) (Table 1).
The mean age for starting to smoke was 18.5 ±
5.9 years (range = 7-36 years), and the mean duration
of smoking was 19.7 ± 12.7 years (range = 2-48 years).
According to FTND results, most smokers (n = 46,
45.5%) had a low level of dependence (p = 0.001). The
degrees of addiction between genders were similar;
44.9% of men and 46.9% of women had low depend-
ence, 26.1% of men and 31.2% of women had moderate
dependence, and 29.0% of men and 21.9% of women
had high dependence (p = 0.725). The GHQ-12 scoresTable 2 Comparison of the gender, risk for mental illness bas
the Fagerström test score levels
Fagerström test scores (n
0-3 point 4
Low dependence M
n = 46 n
Gender Male (n = 69) 31 (44.9%) 1
Female (n = 32) 15 (46.9%) 1
GHQ-12 Positive (n = 38) 10 (26.3%) 1
Negative (n = 63) 36 (57.1%) 1
HADS anxiety Positive (n = 17) 4 (23.5%) 5
Negative (n = 84) 42 (50.0%) 2
HADS depression Positive (n = 23) 6 (26.1%) 8
Negative (n = 78) 40 (51.3%) 2
†p < 0.05, ††p < 0.01, *A linear by linear association chi-square test was used.were above the cut-off threshold in 38 (37.6%) of the
smokers. The rates of low, moderate, and high depend-
ence for GHQ-12 positive smokers were 26.3%, 34.2%,
and 39.5%, respectively. Among GHQ-12 negative
smokers, 57.1% had low dependence, 23.8% had mod-
erate dependence, and 19.0% had high dependence.
GHQ-12 positivity and the degree of nicotine dependence
were significantly related. GHQ-12 positive smokers had
higher mean FTND scores (5.03 ± 2.5) than the GHQ-12
negative smokers (3.57 ± 2.9) (p = 0.011). Of the 38 smokers
who reported a positive mental illness, 17 people (44.7%)
were above the HADS cut-off point for anxiety (10/11) and
23 people (60.5%) were above the cut-off point for depres-
sion (7/8) in the smoker group. We found that as the level
of nicotine dependence increased, the anxiety and depres-
sion scores also increased (p = 0.022 and p = 0.037, respect-
ively) (Table 2).
Table 3 presents the results of the multiple regression
analysis that estimates the simultaneous effects of age,
gender, marital status, mean income, educational status,
alcohol consumption and the risk for anxiety and de-
pression based on HADS. These analyses suggested that
there were no significant effects of age, gender and edu-
cational status on smoking. Smokers are more likely to
be single, widowed or divorced than married (p = 0.024),
and the mean income level seems to have a limited ef-
fect on smoking (p = 0.034). Our results indicated that
alcohol consumption (p = 0.000) and the risk for depres-
sion based on HADS (p = 0.019) were the most effective
factors on the smoking status of the participants. There
was no statistically significant relationship between the
risk for anxiety based on HADS (p = 0.107).
Discussion
We screened treatment-seeking smokers for their mental
health status and used validated scales to assess whethered on GHQ-12 and HADS among smokers according to
= 101) X2* P
-6 point 7-10 point
edium dependence High dependence
= 28 n = 27
8 (26.1%) 20 (29.0%) 0.6 0.725
0 (31.2%) 7 (21.9%)
3 (34.2%) 15 (39.5%) 9.6 0.008††
5 (23.8%) 12 (19.0%)
(29.4%) 8 (47.1%) 5.3 0.022†
3 (27.4%) 19 (22.6%)
(34.8%) 9 (39.1%) 4.4 0.037†
0 (25.6%) 18 (23.1%)
Table 3 Multiple logistic regression results estimating the factors that affect the smoking status of smokers admitted
to the smoking cessation clinic from 1 June 2012 to 31 August 2012
Exp
(B)
95.0% C.I. for Exp B p
Lower Upper
Age (Year) 1.004 0.97 1.04 0.799
Gender (Male) 0.713 0.32 1.55 0.395
Marital status (Married) 3.432 1.18 9.98 0.024†
Mean income Higher than three times the base wage rate - 0.034†
Base wage rate or lower 0.339 0.08 1.29 0.115
Two or three times the base wage rate 0.223 0.07 0.70 0.011†
Educational status University or higher - 0.615
Primary school and under 1.701 0.17 16.2 0.644
High school 1.046 0.12 8.80 0.967
Alcohol consumption (+)* 10.972 3.61 33.2 0.000††
Positive risk for anxiety based on HADS 3.414 0.76 15.2 0.107
Positive risk for depression based on HADS 4.728 1.28 17.3 0.019†
†p < 0.05, ††p < 0.01, *Alcohol use more than 2 drinks/day for males and 1 drink/day for females (1 drink = ½ oz or 15 ml ethanol).
Emre et al. Tobacco Induced Diseases 2014, 12:20 Page 5 of 7
http://www.tobaccoinduceddiseases.com/content/12/1/20they have a risk of developing anxiety and depression.
The risk for mental illness was significantly higher in
smokers than in the non-smoking comparison group
participants. The risk for anxiety and depression was
higher among smokers, and the mental health scores in-
creased with the nicotine addiction severity. The follow-
ing factors were independently related to smoking: being
unmarried, having a high personal income, alcohol use
and a high risk for depression based on HADS according
to multivariate analysis.
Alcohol use and smoking are strongly associated with
each other. Smokers may have a 2 to 3 times higher risk
of alcohol dependence than non-smokers [20-22]. Grant
et al. [23] showed that nicotine addiction was the most
prevalent among individuals with a current alcohol or
drug use disorder, and there was a strong association be-
tween nicotine addiction and specific mood, anxiety and
personality disorders in the total population and by gen-
der. We found that the alcohol consumption rate in the
smoker group was six times higher than the comparison
group.
The mental illness risk among smokers is higher than
that of non-smokers. Approximately 30% of smokers are
estimated to have mental illness, and depression and anx-
iety symptoms are observed more often among smokers
than non-smokers [24-28]. Degenhard et al. [29] found
that current tobacco use is associated with a range of
other substance use and mental health problems. They
noted that those problems were likely to reduce the suc-
cess of attempts to quit smoking; therefore, the presence
of other substance use and mental health problems needs
to be considered with smoking-cessation treatment [29].
The rate of high scores above the cut-off threshold for
mental illness according the GHQ-12 results was high(37.6%) in the smoker group, and the risk for anxiety and
depression was significantly higher for smokers compared
to non-smokers.
Cosci et al. [30] assessed whether subjects applying to
smoking cessation clinics display a higher level of affective
symptoms than smokers recruited from the general popu-
lation. Their cases had significantly higher scores than
controls when the rating scales assessed anxious and
depressive symptoms. The cases scored higher on the
anxiety subscale of the HADS (p < 0.005) than controls.
Additionally, the cases had a higher mean score for the
HADS depression subscale than controls, but this re-
sult was not significantly different (p = 0.1076) [30].
We found that smokers scored higher on the anxiety
(p = 0.006) and depression subscales (p = 0.001) of the
HADS than the comparison group in our study. Al-
though there was a significant relationship between
smoking and the risk for depression, based on HADS,
according to the multivariate analysis, there was no
significant relationship with the risk for anxiety.
Jamal et al. [31] compared the severity of nicotine ad-
diction and the course of the symptoms of depression
and anxiety between smokers and non-smokers. They
found that heavy smoking and nicotine addiction were
associated with depression and anxiety and that the de-
pressive symptom severity was higher among heavier
smokers [30]. We also found that smokers had an in-
creased risk of anxiety and depression, which was associ-
ated with an increased severity of nicotine addiction.
Raising public awareness, reducing young people’s access
to tobacco and implementing tobacco laws and smoking
policies are very important for preventing people from the
harmful effects of smoking. Smoking cessation is the most
important, cost-effective treatment that clinicians can offer
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can take many years, and it is a challenging process that
often requires more than one quitting attempt [9].
Limitations
This study includes some limitations with respect to the
generalizability because the study does not include a
large sample size. Another limitation is the comparison
group. We have some concerns about whether they
match the same hypothetical population as the smokers
even though they are age- and gender-matched and have
a similar education level.
Conclusions
In recent years, many smoking cessation clinics have been
established across Turkey. Health professionals who work
in these clinics should be well-trained, and services should
be provided from a multidisciplinary perspective. Our re-
search results and those from many other studies on simi-
lar topics have shown that smokers have high scores for
probable mental illness. Therefore, it is important to
screen all smokers who want to quit smoking for mental
health disorders using valid scales, and referring smokers
who are at a high risk of mental illness to mental health
professionals should always be considered.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
NE conceived of the study, performed the literature review and conducted
data collection; KT participated in the design of the study and coordination;
NB conceived of the study and performed the statistical analysis; and ET
participated in its design and helped to draft the manuscript. All authors
read and approved the final manuscript.
Acknowledgements
We would like to thank Prof. Esra Saatci for her valuable guidance and
advice.
Author details
1Department of Family Medicine, Pamukkale University Faculty of Medicine,
C103, 20070, Kinikli, Denizli, Turkey. 2Denizli State Hospital, Chest Diseases
Clinic, No 1, 20010 Denizli, Turkey.
Received: 13 June 2014 Accepted: 27 October 2014
Published: 4 November 2014
References
1. World Health Organization: WHO Report on the Global Tobacco Epidemic,
2008, The MPOWER Package. Geneva: WHO; 2008. www.who.int/tobacco/
mpower/mpower_report_full_2008.pdf.
2. World Health Organization: Global Status Report on Noncommunicable
Diseases 2010, Description of the global burden of NCDs, their risk factors and
determinants. Geneva: WHO; 2011. http://whqlibdoc.who.int/publications/
2011/9789240686458_eng.pdf.
3. Bartecchi CE, MacKenzie TD, Schrier RW: The human costs of tobacco use.
N Engl J Med 1994, 331:618.
4. Breslau N, Kilbey MM, Andreski P: Nicotine dependence and major
depression. New evidence from a prospective investigation. Arch Gen
Psychiatry 1993, 50:31–35.
5. American Psychiatric Association: Diagnostic and Statistical Manual of Mental
Disorders. 4th edition. Washington, DC: American Psychiatric Association; 2000.6. Uneri O, Tural U, Memik CN: Smoking and schizophrenia: where is the
biological connection? Turk Psikyiatri Derg 2006, 17:55–64.
7. Karlıkaya C, Öztuna F, Solak ZA, Özkan M, Örsel O: Tobacco control. Turk
Toraks Derg 2006, 7:51–64.
8. Lam TH, Stewart SM, Ho SY, Lai MK, Mak KH, Chau KV, Rao U, Salili F:
Depressive symptoms and smoking among Hong Kong Chinese
adolescents. Addiction 2005, 100:1003–1011.
9. McManus S, Howard Meltzer H, Campion J: Cigarette Smoking and Mental
Health in England, Data from the Adult Psychiatric Morbidity Survey 2007.
London: National Center for Soocial Research; 2010. http://www.natcen.ac.
uk/media/21994/smoking-mental-health.pdf.
10. Breslau N, Kilbey M, Andreski P: Nicotine dependence, major
depression, and anxiety in young adults. Arch Gen Psychiatry 1991,
48:1069–1074.
11. Black DW, Zimmerman M, Coryell WH: Cigarette smoking and
psychiatric disorder in a community sample. Ann Clin Psychiatry 1999,
11:129–136.
12. Fagerström KO, Kunze M, Schoberberger R, Breslau N, Hughes JR, Hurt RD,
Puska P, Ramström L, Zatoński W: Nicotine dependence versus smoking
prevalence: comparisons among countries and categories of smokers.
Tob Control 1996, 5:52–56.
13. Uysal MA, Kadakal F, Karşıdağ Ç, Bayram NG, Uysal Ö, Yılmaz V: Fagerstrom
test for nicotine dependance: reliability in a Turkish sample and factor
analysis. Tuberk Toraks 2004, 52:115–121.
14. Goldberg DP: The Detection of Psychiatric Illness by Questionnaire. London:
Oxford University Press; 1972.
15. Özdemir H, Rezaki M: General Health Questionnaire-12 for the detection
of depression. Turk Psikyiatri Derg 2007, 18:13–21.
16. Kılıç C: The reliability and validity study of General Health Questionnaire.
Turk Psikyiatri Derg 1996, 7:3–9.
17. Kılıç C, Rezaki M, Rezaki B, Kaplan I, Ozgen G, Sağduyu A, Oztürk MO: General
Health Questionnaire (GHQ-12 & GHQ-28): psychometric properties and factor
structure of the scales in a Turkish primary care sample. Soc Psychiatry Psychiatr
Epidemiol 1997, 32:327–331.
18. Zigmond AS, Snaith PR: The hospital anxiety and depression scale. Acta
Psychiatr Scand 1983, 67:361–370.
19. Aydemir Ö, Güvenir T, Küey L, Kültür S: Validity and reliability of Turkish
version of Hospital Anxiety and Depression Scale. Turk Psikyiatri Derg
1977, 8:280–287.
20. Drobes DJ: Concurrent alcohol and tobacco dependence: mechanisms
and treatment. Alcohol Res Health 2002, 26:136–142.
21. Breslau N: Psychiatric comorbidity of smoking and nicotine dependence.
Behav Genet 1995, 25:95–101.
22. Room R: Smoking and drinking as complementary behaviours. Biomed
Pharmacother 2004, 58:111–115.
23. Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA: Nicotine dependence
and psychiatric disorders in the United States: results from the national
epidemiologic survey on alcohol and related conditions. Arch Gen
Psychiatry 2004, 61:1107–1115.
24. Anthony JC, Warner L, Kessler R: Comparative epidemiology of
dependence on tobacco, alcohol, controlled substances and inhalants.
Basic findings from the National Comorbidity Survey. Exp Clin
Psychopharmacol 1994, 2:244–268.
25. Fiore MC, Bailey WC, Cohen SJ, Dorfman SF, Goldstein MG, Gritz ER, Heyman RB,
Jaén CR, Kottke TE, Lando HA, Mecklenburg RE, Mullen PD, Nett LM, Robinson L,
Stitzer ML, Tommasello AC, Villejo L, Wewers ME: Treating Tobacco Use and
Dependence. Quick Reference Guide for Clinicians. Rockville: U.S. Department of
Health and Human Services; 2000. https://health.state.tn.us/Downloads/
TQL_Quick%20Reference.pdf.
26. Horn K, Dino G, Kalsekar I, Massey CJ, Tennant KM, McGloin T: Exploring the
relationship between mental health and smoking cessation: a study of
rural teens. Prev Sci 2004, 5:113–126.
27. Berlin I, Chen H, Covey LS: Depressive mood, suicide ideation and anxiety
in smokers who do and smokers who do not manage to stop smoking
after a target quit day. Addiction 2010, 105:2209–2216.
28. Moylan S, Jacka FN, Pasco JA, Berk M: Cigarette smoking, nicotine dependence
and anxiety disorders: a systematic review of population-based,
epidemiological studies. BMC Med 2012, 10:123.
29. Degenhardt L, Hall W: The relationship between tobacco use, substance-use
disorders and mental health: results from the National Survey of Mental
Health and Well-being. Nicotine Tob Res 2001, 3:225–234.
Emre et al. Tobacco Induced Diseases 2014, 12:20 Page 7 of 7
http://www.tobaccoinduceddiseases.com/content/12/1/2030. Cosci F, Schruers KR, Pistelli F, Griez EJ: Negative affectivity in smokers
applying to smoking cessation clinics: a case–control study. Depress Anxiety
2009, 26(9):824–830.
31. Jamal M, Van der Does AJW, Cuijpers P, Penninx BWJH: Association of
smoking and nicotine dependence with severity and course of
symptoms in patients with depressive or anxiety disorder. Drug Alcohol
Depend 2012, 126:138–146.
32. Anczak JD, Nogler RA 2nd: Tobacco cessation in primary care: maximizing
intervention strategies. Clin Med Res 2003, 1:201–216.
doi:10.1186/1617-9625-12-20
Cite this article as: Emre et al.: Mental health screening and increased risk
for anxiety and depression among treatment-seeking smokers. Tobacco
Induced Diseases 2014 12:20.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
